Valuation Cuorips Inc.

Stocks

Delayed Japan Exchange Other stock markets 02:30:00 2026-08-10 EDT			5-day change	1st Jan Change
5,400.00 ^JPY	+7.78%		+19.07%	-10.45%

02-19	Japan Panel Clears First iPS Cell Therapies for Conditional Sale	MT
02-19	Japanese government panel endorses Sumitomo Pharma's iPS-derived treatment for Parkinson's	RE

Data adjusted to current consolidation scope

Fiscal Period: March	2024	2025	2026
Market Cap ¹	29,126	67,173	57,885
Change	-	130.63%	-13.83%
Enterprise Value (EV) ¹	23,544	62,380	53,986
Change	-	164.96%	-13.46%
P/E	-43x	-103x	-56.3x
PBR	4.91x	12.2x	12.2x
PEG	-	16.48x	-1x
Capitalization / Revenue	1,266x	384x	273x
EV / Revenue	1,024x	356x	255x
EV / EBITDA	-45.5x	-121x	-54.1x
EV / EBIT	-40x	-106x	-49.9x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-85.84	-80.48	-124.5
Distribution rate	-	-	-
Net sales ¹	23	175	212
EBITDA ¹	-518	-514	-997
EBIT ¹	-588	-590	-1,081
Net income ¹	-632	-644	-1,022
Net Debt ¹	-5,582	-4,793	-3,899
Reference price ²	3,695.00	8,310.00	7,010.00
Nbr of stocks (in thousands)	7,882	8,083	8,258
Announcement Date	6/27/24	6/20/25	6/24/26

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CUORIPS INC.	-	-	-	-	281M
REGENERON PHARMACEUTICALS, INC.	19.09x	4.37x	10.28x	0.48%	80.69B
SAMSUNG BIOLOGICS CO.,LTD.	38.21x	13.07x	24.87x	-.--%	51.22B
UCB	22.71x	4.98x	14.44x	0.65%	49.58B
CSL LIMITED	-61.04x	3.52x	10.42x	3.01%	45.5B
BIOGEN INC.	36.8x	3.41x	12.97x	-.--%	30.6B
INCYTE CORPORATION	54.24x	3.43x	26.59x	-.--%	24.64B
MODERNA, INC.	-6.97x	9.6x	-6.2x	-.--%	23.88B
INNOVENT BIOLOGICS, INC.	72.93x	6.99x	45.98x	-.--%	21.59B
ALTEOGEN INC.	55.77x	51.21x	64.37x	0.13%	17.09B
Average	25.75x	11.18x	22.64x	0.47%	34.51B
Weighted average by Cap.	19.34x	8.33x	18.24x	0.61%